DHT And Hair Loss
Daily Health & Beauty
Hair Loss Hub
The Hormone Behind Most Hair Loss
Dihydrotestosterone — DHT — is the primary driver of androgenetic alopecia in both men and women. Understanding what it is, how it works, and how to address it is the foundation of effective hair loss treatment.
If you are experiencing pattern hair loss — thinning at the crown, a receding hairline, or diffuse thinning across the top of the scalp — DHT is almost certainly involved. It is the single most studied and clinically significant factor in androgenetic alopecia, affecting both men and women, and it operates through a precise biological mechanism that can be understood and addressed.
What Is DHT?
Dihydrotestosterone (DHT) is an androgen — a sex hormone — derived from testosterone. The conversion happens via an enzyme called 5-alpha reductase (5-AR), which is present in skin, liver, and hair follicles. DHT is approximately 2–5 times more potent than testosterone at the androgen receptor.
In most tissues, DHT plays normal physiological roles. In hair follicles on the scalp — in people with a genetic predisposition — DHT binds to androgen receptors in the dermal papilla and triggers a cascade that progressively shortens the hair growth cycle and shrinks the follicle itself.
"DHT does not cause hair loss in everyone — it causes hair loss in those whose follicles are genetically sensitive to it. The hormone is the trigger; the follicle's sensitivity is the loaded gun."
— Daily Health & Beauty Editorial
How DHT Causes Hair Loss
The mechanism is called follicular miniaturization. When DHT binds to androgen receptors in the dermal papilla, it disrupts the normal signaling that sustains the anagen (growth) phase. Over successive hair cycles, the anagen phase becomes progressively shorter while the telogen (resting) phase lengthens.
The result: each new hair that grows is thinner, shorter, and lighter than the one before it. Eventually the follicle may produce only a fine, nearly invisible vellus hair — or stop producing hair entirely. This process unfolds over years to decades, which is why early intervention matters so much.
Stage 1 — Early Miniaturization
Anagen phase begins to shorten. Hairs grow slightly thinner and may not reach their previous length. Shedding may increase slightly. Often unnoticeable without close comparison photos.
Stage 2 — Progressive Thinning
Visible reduction in density in affected areas. Hairs are noticeably finer. The scalp may become more visible through the hair. This is typically when most people first seek treatment.
Stage 3 — Advanced Miniaturization
Follicles produce only vellus (fine, unpigmented) hairs or become dormant. Significant visible thinning or baldness. Follicles may still be recoverable with treatment if not fully dormant.
DHT And Women
DHT-driven hair loss is not exclusive to men. Women produce testosterone — and therefore DHT — in smaller amounts via the adrenal glands and ovaries. Women with androgenetic alopecia typically experience diffuse thinning across the crown and top of the scalp rather than the defined recession pattern seen in men.
Hormonal shifts that reduce estrogen — menopause, postpartum recovery, stopping hormonal contraceptives — can increase the relative androgenic effect of DHT on follicles, triggering or accelerating thinning. This is why female hair loss often intensifies at specific life stages.
Hair Loss At Daily Health & Beauty
Target DHT At The Follicle Level
Shop shampoos, serums, supplements, scalp tools, and our DH&B Curated bundles — formulated to support healthier-looking hair.
Shop Hair Loss Products ↓Addressing DHT-Driven Hair Loss
Effective approaches target DHT at one of two points: reducing its production or blocking its effect at the follicle. Cosmetic formulations — including FOLIGAIN®'s TRIOXIDIL® complex — are designed to support scalp and follicle health in ways that may reduce the visible impact of DHT-related miniaturization.
Key Approaches
- 5-AR inhibitors (prescription): Finasteride and dutasteride reduce DHT production systemically. Prescription only. Consult a physician.
- Topical DHT-blocking ingredients: Cosmetic formulations containing saw palmetto, ketoconazole, and other compounds may reduce DHT activity at the scalp level.
- Minoxidil: Does not block DHT but prolongs the anagen phase and improves follicle blood supply — often used alongside DHT-targeting approaches.
- Scalp health support: Reducing scalp inflammation — a co-factor in DHT-driven miniaturization — through regular cleansing, exfoliation, and targeted serums.
Why Early Intervention Matters
Follicular miniaturization is a progressive process. A follicle in early miniaturization — still producing a visible, pigmented hair — is far more responsive to treatment than one that has been dormant for years. The window for meaningful intervention is widest at the earliest stages of thinning.
By the time most people notice significant thinning, they have typically lost 30–50% of density in the affected area. This is not a reason for despair — it is a reason to act now rather than later.
The Bottom Line
DHT is the mechanism. Early, consistent treatment is the response.
Understanding the hormone driving your hair loss is the first step. The second is acting on that understanding before miniaturization advances further.
This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare professional for diagnosis and treatment of hair loss conditions.
Further Reading
Hair Loss Resources
Hub
Hair Loss Hub — Causes, Treatments & Solutions
Explore The Full Hub →
Shop The Collection
